Zoetis Inc. $ZTS Shares Sold by Texas Capital Bank Wealth Management Services Inc

Texas Capital Bank Wealth Management Services Inc trimmed its position in Zoetis Inc. (NYSE:ZTS) by 16.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,975 shares of the company’s stock after selling 8,303 shares during the period. Texas Capital Bank Wealth Management Services Inc’s holdings in Zoetis were worth $5,995,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Zoetis by 1.0% during the third quarter. Vanguard Group Inc. now owns 42,306,764 shares of the company’s stock worth $6,190,326,000 after buying an additional 419,777 shares in the last quarter. Norges Bank purchased a new position in shares of Zoetis during the second quarter valued at approximately $809,491,000. Brown Advisory Inc. boosted its position in Zoetis by 5.7% during the second quarter. Brown Advisory Inc. now owns 4,659,371 shares of the company’s stock worth $726,629,000 after acquiring an additional 250,829 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Zoetis by 14.6% during the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,312,779 shares of the company’s stock worth $631,046,000 after acquiring an additional 550,859 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Zoetis by 2.3% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 3,585,702 shares of the company’s stock worth $559,192,000 after acquiring an additional 82,012 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Barclays began coverage on Zoetis in a report on Monday, December 8th. They issued an “equal weight” rating and a $136.00 price target for the company. UBS Group set a $136.00 price objective on Zoetis in a research report on Thursday, January 29th. BTIG Research reiterated a “buy” rating and issued a $160.00 target price on shares of Zoetis in a research note on Thursday, February 26th. The Goldman Sachs Group upgraded Zoetis to a “buy” rating in a research report on Monday, December 15th. Finally, Leerink Partners reissued a “market perform” rating on shares of Zoetis in a research note on Tuesday. Six research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $152.91.

Zoetis Stock Performance

NYSE:ZTS opened at $115.62 on Friday. The company has a market cap of $48.81 billion, a P/E ratio of 19.21, a P/E/G ratio of 1.76 and a beta of 0.95. The firm’s 50 day moving average is $125.34 and its two-hundred day moving average is $131.91. Zoetis Inc. has a fifty-two week low of $114.47 and a fifty-two week high of $172.23. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s payout ratio is 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.